Tuesday, January 31, 2012

DEC-1 World AIDS Day

Backed by the United Nations, the "Getting to Zero" campaign runs until 2015 and builds on last year’s successful World AIDS Day "Light for Rights" initiative encompassing a range of vital issues identified by key affected populations.The decision to go with the millennium development related goal of "Getting to Zero" comes after extensive discussions among people living with HIV, health activists, broader civil society and many others – more than a hundred organizations in all.The vision for this year’s World AIDS Day and beyond may be aspirational, but the journey towards its attainment is laid with concrete milestones.                   
  10 goals for 2015
· Sexual transmission of HIV reduced by half, including among young people, men who have sex with men and transmission in the context of sex work;
· Vertical transmission of HIV eliminated and AIDS-related maternal deaths reduced by half;
· All new HIV infections prevented among people who use drugs;
· Universal access to antiretroviral therapy for people living with HIV who are eligible for treatment;
· TB deaths among people living with HIV reduced by half;
· All people living with HIV and households affected by HIV are addressed in all national social protection strategies and have access to essential care and support;
· Countries with punitive laws and practices around HIV transmission, sex work, drug use or homosexuality that block effective responses reduced by half;
· HIV-related restrictions on entry, stay and residence eliminated in half of the countries that have such restrictions;
· HIV-specific needs of women and girls are addressed in at least half of all national HIV responses;
· Zero tolerance for gender-based violence..
In Siddha system RAN Therayhy is found to be very effective in the treatment of HIV infected persons by increasing the Immune status. It was proved by comparing the RTPCR levels of the diseased persons. The incidence of Opportunistic Infections  were  reduced for those undergoing Siddha Treatment.

 

Thursday, January 5, 2012

From the Editors Desk


                                                              

           WIPEOUT –BLAME TO SIDDHA
                 
                  We ,again and again, hearing the words that the siddha drugs are hepatotoxic and they leads to Renal failure. We all know that drugs are more safe, if it is being proceed as per proper procedure mentioned in the literatures by great siddhars.
It is a planed threat are being make by the modern drug       industry to protect their trade. Many multi national  Pharma          industries are repeatedly doing this false propaganda as a chain movement. We siddha professional should be aware to counter this allegation against our system.
It is surprise that, in ’FOLIC ACID’ default-drug used for pregnancy supplement therapy is  being processed with nearly 26 incredients, among which one is sodium cyanide, which is a very dangerous poison, but in the end product, they are claiming that there is no such poisonous incredients. This is being accepted by whole scientific community. But in our drug Rasagandhi Mezhugu we are assure that at the end product there will not any trace of mercury. They are not accepting this concept. 
See the difference in the facts behind
Folic acid & Rasagandhi Mezhugu.
         Yours
D.Velayudam    







A PILOT STUDY ON MANAGEMENT OF MADHUMEGAM (DIABETES MELLITUS TYPE-II)


 A PILOT STUDY ON MANAGEMENT OF MADHUMEGAM (DIABETES MELLITUS TYPE-II)                                                                      

  



National Institute of Siddha Every day, thousands of patients are getting benefit for their illness. Among them, patients suffering with Madhumegam(diabetes)are more common. Many of them are taking medicines for a long period. Some of them are taking only siddha medicines, and some of them are taking siddha medicines combined with allopathic medicines. They take siddha medicine before or after food as per the prescription of physicians. They take Nilavembu kudineer along with Madumegacapsules ,Kilanelli tablet and Tripala tablet. It is a need to rule out which of the above criteria is the most beneficial for the patient to manage Madhumegam. So we have planned to do a pilot study on the management of Madhumegam patients in NIS as a Retrospective study.
 OBJECTIVE OF THE PILOT STUDY
Comparison of two groups of MM patients-taking siddha medicine alone and combined with Allopathy medicine .Comparison of MM patients having food habits of Vegetarian & Non-vegetarian diets .Comparison of medicines taken before the food and after the food.Efficacy of MMC capsule alone and along with                                   NV kudineer.Comparison of blood sugar level, Hb, and Cholesterol before taking the treatment and at the latest     report of assessment.
OBSERVATIONS
 In NIS, 40 % of Madhumegam(Diabetic) patients belong to Group I ( i.e taking siddha medicine only ) and 60% belong to Group II ( i.e taking both siddha and allopathy medicines ).This  indicates that the users of both  siddha and allopathy medicines are higher than users of siddha medicines alone .
54% of Madumegam patients are due to hereditary. 73% of  people taking non vegetarian food are affected with MM,  and it is  higher than the people taking vegetarian food (27%).89% of MM patients are undergoing periodic lab investigations once in 3 months. Most of the MM patients(78%) are taking MMC capsule along with Nilavembu kudineer. 52% of Madumegam patients  are taking siddha medicine after food and , 48%  are taking before food.  Among MM patients, 59% are also affected  with Hypertension. The mean ±S.D of blood sugar at fasting before and after treatment were 150±50 and 122±35 respectively for siddha alone group, whereas for siddha and allopathy group,these were 146±47 and 144±47 respectively. The statistical analysis reveals that the reduction of blood sugar for(siddha only) Group I at fasting was statistically significant(P<0.0001) and Group-II(siddha and allopathy) it was not significant(P=0.73). The mean±S.D of blood sugar at postprandial before and after treatment were 247±77 and 178±64 respectively for siddha alone group, whereas for siddha and allopathy group, these were 237±85 and229 ±80 respectively. The statistical analysis reveals that the reduction of blood sugar for(siddha only) Group I at postprandial was statistically significant(P<0.0001) and Group-II(siddha and allopathy) it was not significant(P=0.55).
The statistical analysis reveals that the increased of  Hemoglobin was statistically significant(P<0.0068)
CONCLUSION
The siddha medicine alone treated group (Group I) shows significant reduction of blood sugar both at fasting and post prandial.The siddha and allopathy treated group(Group II) has not shown significant reduction.   Dr .A.Kirubagaan

KNOW ABOUT HERB


KNOW ABOUT HERB

 Botanica Name : Syzygium cumini (L.) Skeels
Tamil Name       : Naval
English Name     : Jambul
Flower                 : White to pinkish
Fruit                   : Dark purplish red
Medicinal Uses  : The seeds are sweet, astringent to bowels and good for diabetes.
The sprouts are refrigerant, carminatives & astringent to bowels. Powdered seeds are
used as a remedy in diabetes and in metrorrhagia . As per siddha system of medicine
they acts as liver tonic, enriches blood, strengthens teeth and gums and forms good
lotion  for removing ringworm infection of the head.

A Study on Aavarai kudineer in the treatment of Madhumegam


A Study on Aavarai kudineer in the treatment of Madhumegam

                   Aavarai kudineer is a well known Siddha poly herbal formulation to treat Madhumegam (Diabetes).
                  A study was undertaken with known diabetes patients(25 ns) for about 45 days, all the patients were clinically assessed by their symptoms such as poly urea, Polphagia, Polydypsia, Nocturia, Tiredness, Burning sensation of soles, Pain in the limbs and Parasthesia. Blood and urine sugar levels both fasting and PP of the patients were  observed before and after the treatment. Patients were given medicines every 5 days and clinical signs and symptoms were monitored and recorded.
Observations:
Naadi – 21 pt are with Valiazhal and 4 pt with Azhalvali tontha naadi.
Dietary style – 17 pt are non vegetarians and 8 pt are vegetarians.
Poly urea – 8 pt shows good reduction, 16 pt shows moderate reduction and 1pt shows no impact.
Poly dypsia -  15 pt shows good reduction, 9 pt shows moderate reduction and 1pt shows no impact.
Poly phagia - 17 pt shows good reduction and 8 pt shows moderate reduction.
Nocturia - 9 pt shows good reduction and 16 pt shows moderate reduction.
Tiredness - 20 pt shows good reduction, 4 pt shows moderate reduction and 1pt shows no impact.
Burning sensation in Soles - 20 pt shows good reduction, and 5 pt shows moderate  reduction.
Pain in the limbs -  15 pt shows good reduction, 9 pt shows moderate reduction and 1pt found to have  no impact.
                   Parasthesia in the feet - 20 pt shows good reduction and 5 pt shows moderate reduction.
Blood parameters - comparing before and after treatment, 5 patients were observed with good reduction, 6 with moderate reduction in sugar levels and others with less impact.
Inference:
The above study shows that in the treatment of Madhumegam Aavarai kudineer responds well in reducing the clinical symptoms in a shorter duration itself. On continuous administration for a longer period it may definitely recovers the patients from Madhumegam.

- Dr.S.Senthil karunakaran.

 

Inhibition of aldose reductase by dietary antioxidant curcumin: Mechanism of inhibition, specificity and significance.


Inhibition of aldose reductase by dietary antioxidant curcumin: Mechanism of inhibition, specificity and significance.

 A b s t r a  c t:
                  Accumulation of intracellular sorbitol due to increased aldose reductase (ALR2) activity has been implicated in the development of various secondary complications of diabetes. In this study we show that curcumin inhibits ALR2 with an IC50 of 10 lM in a non-competitive manner, but is a poor inhibitor of closely-related members of the aldo-keto reductase superfamily, particularly aldehyde reductase. Results from molecular docking studies are consistent with the pattern of inhibition of ALR2 by curcumin and its specificity. Moreover, curcumin is able to suppress sorbitol accumulation
in human erythrocytes under high glucose conditions, demonstrating an in vivo potential of curcumin to prevent sorbitol accumulation. These results suggest that curcumin holds promise as an agent to prevent or treat diabetic complications.
2009 Federation of European Biochemical Societies. Published by Elsevier B.V.


Raagi or Kelvaraghu Koozh Recipe:


   Raagi or Kelvaraghu Koozh Recipe:
 Ingredients:
Ragi (Finger millet) flour – 4 tab.spo
 Salt – as required
Butter Milk – 3 tumbler
Water- 3 tumbler
Chopped onion – handfull
Cooked rice – 1 tablespoon
Method:
1. Mix Ragi flour in 1 cup of Water without any lumps.
2. Heat remaining Water in a vessel.
3. Once it started to boil, add mixed Ragi flour in medium flame.
4. Allow the Ragi flour mix to boil until it thickens.
5. Finally add cooked rice, salt, chopped onion and remove from flame.
6. Allow it to cool for some time and add butter milk while serving.
Uses:
This ragi itself is a good ingredient for those dieting and also a rich fibre food good for  physical woker ,diabetic patients,and ladies specially .